{"id":"W2164958589","doi":"10.1007/s00345-014-1244-2","title":"Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder","year":2014,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Astellas Pharma","keywords":"Mirabegron; Tolerability; Overactive bladder; Medicine; Placebo; Urology; Onset of action; Internal medicine; Clinical trial; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004151812,0.00008752196,0.0007905218,0.0003238448,0.00002747773,0.000002766091,0.00008258356,0.00007487841,0.0001835382],"category_scores_gemma":[0.001087726,0.00005057748,0.000102007,0.000227058,0.0002435292,0.00007545837,0.00004569499,0.000656107,3.76563e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000025278,"about_ca_system_score_gemma":0.0001855842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003524701,"about_ca_topic_score_gemma":0.0001470838,"domain_scores_codex":[0.9968139,0.001544709,0.001107494,0.0001148012,0.0002598763,0.0001592044],"domain_scores_gemma":[0.997437,0.001336724,0.0008154821,0.0001378174,0.0001907729,0.00008217741],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05775081,0.003799591,0.8946221,0.00004723487,0.0002675888,0.00002544262,0.0006442199,0.00001502618,0.00107849,0.00002750145,0.001172381,0.04054958],"study_design_scores_gemma":[0.03175066,0.01812386,0.9446715,0.00008459633,0.0001502955,0.00006348485,0.00007447434,0.00004996492,0.0008787056,0.0002043947,0.003891681,0.00005644993],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972714,0.0002107934,0.00002197452,0.001811315,0.0001376077,0.0002874355,0.000008832259,8.849117e-7,0.0002497415],"genre_scores_gemma":[0.9993855,0.0001643701,0.00007118549,0.0001705928,0.00008348534,0.000001737628,0.000002891172,0.00000789812,0.0001123119],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05004929,"threshold_uncertainty_score":0.2850495,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06621683943050793,"score_gpt":0.4164029860685041,"score_spread":0.3501861466379962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}